A Cp*Co III -catalyzed arene C–H bond amidation/annulation of benzamides was developed to afford quinazolinone derivatives in one-pot with high yields and broad substrate scope.
Switching the site-selectivity of C–H activation in aryl sulfonamides containing strongly coordinating N-heterocycles was achieved using a RhIII-catalyst.
A rhodium(III)-catalyzed sulfonamide directed ortho C–H carbenoid functionalization has been developed with good yields. This method is attractive due to its broad substrate scope, and enables derivation of diverse biologically active sulfonamide structures and late-stage modification of sulfa drugs.